Medicine Price Update: Nowadays, medical costs are on the rise. This is particularly challenging for individuals who need to take medications daily for conditions like blood pressure, diabetes, heart disease, or other serious health issues, as they face significant monthly expenses for their prescriptions. In light of this, the central government has provided substantial relief to the public. The National Pharmaceutical Pricing Authority (NPPA) has established the retail prices for 39 medications, which include treatments for high blood pressure, diabetes, and heart disease.
According to a notice from the Ministry of Chemicals and Fertilizers, the NPPA has set the retail prices for 39 new drug formulations under the Drugs (Prices Control) Order (DPCO), 2013. This initiative aims to make essential medications more affordable for everyone.
The government has fixed prices for several crucial medications, including:
– Hypertension
– Diabetes
– Heart disease
– Eye infections
– Drugs related to stroke and heart attack
– Blood clot-dissolving medications
– Allergy and other medical treatments
– HIV
With these new price regulations, patients are anticipated to experience relief from fluctuating costs.
Highlighting a key medication: Clot-busting injections
Among the most costly drugs listed by the NPPA is the Tenecteplase (TNK TPA) injection, a sophisticated “clot-busting” medication used to eliminate harmful blood clots during heart attacks and other critical situations. The government has set its price at Rs 60,238.27 per vial. In contrast, amlodipine bisoprolol telmisartan tablets, which are prescribed for hypertension, are priced at Rs 14.74 per tablet.
The retail price of Nepafenac Moxifloxacin Ophthalmic Solution, an eye drop used after eye surgery and to treat bacterial infections in the eyes, has been fixed at Rs 68.64 per ml. Clopidogrel+ Aspirin+Atorvastatin capsules, given to reduce the risk of heart attack and stroke, have been fixed at Rs 6.37 per capsule. The prices of Amoxicilline+Clavulanate tablets and dispersible tablets, used to treat infections, eye drops used to treat glaucoma, HIV therapy kits, Vitamin D3 Oral Solution, and Imatinib Oral Solution, used to treat cancer, have also been fixed.
What if the medical store charges more?
The government has also issued a strict warning in this matter. According to the NPPA order, if any company or marketing entity charges more than the fixed price, it should: The entire excess amount charged will have to be refunded.Interest will also have to be paid on it. May face action under DPCO 2013 and Essential Commodities Act, 1955. It is mandatory for shopkeepers to display price lists. NPPA has once again clarified that it is mandatory for all retailers and dealers to clearly display the price list issued by the manufacturing companies in their shops. Citing Para 24(4) of the DPCO 2013, the authority said that every retailer and dealer shall display the price list and supplementary price list in such part of his shop where it is easily visible and accessible to any customer.